20/20 BIOLABS, INC. Financing Receivable, Percent Past Due
20/20 BIOLABS, INC. (AIDX) had Financing Receivable, Percent Past Due of 20.00% as of 2025-12-31, per its POS AM filed 2026-04-06.
Financial Statements › Notes
us-gaap:FinancingReceivablePercentPastDue1 · last filed 2026-04-06
- 2025-12-31: Financing Receivable, Percent Past Due 20.00%.
| Period end | Financing Receivable, Percent Past Due |
|---|---|
| 2025-12-31 | 20.00% POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |